Source: Drug Store News

Sunovion: Lupin to acquire 2 inhalation brands from Sunovion

Lupin is acquiring Brovana inhalation solution and Xopenex HFA inhalation aerosol, from Sunovion for $75 million.

Read full article »
Sunovion's Competitors | Sunovion's News | Sunovion's Financials
Stay up-to-date with the latest news on Sunovion
Est. Annual Revenue
$500M-1.0B
Est. Employees
500-1.0K
Antony Loebel's photo - President & CEO of Sunovion

President & CEO

Antony Loebel

CEO Approval Rating

86/100

Read more
Stay up-to-date with the latest news on Sunovion